CASTLE MEDICAL GROUP PRACTICE — All Prescriptions & Medications — Page 7
Practice Code: E81013 | LUTON, LU1 3AG
Showing results 301-350 of 618
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 68 | 850 | £173 | +134.8% ▲ | |
| Alverine citrate | 67 | 7,934 | £403 | +61.9% ▲ |
| Powder 1.6 kcal/ml milkshake (0913011) | 67 | 12.7K | £921 | -10.1% ▼ |
| Betamethasone esters | 67 | 3,810 | £473 | +11.1% ▲ |
| Hydrocortisone | 66 | 1,371 | £315 | -13.1% ▼ |
| Fesoterodine fumarate | 66 | 2,184 | £184 | +67.3% ▲ |
| 66 | 1,185 | £1.0K | +78.2% ▲ | |
| Cinnarizine | 65 | 7,788 | £353 | +38.9% ▲ |
| Neomycin sulfate | 65 | 1,035 | £131 | +9.6% ▲ |
| Metoprolol tartrate | 64 | 2,408 | £959 | +26.2% ▲ |
| Lacidipine | 64 | 3,556 | £298 | -46.4% ▼ |
| Ketone blood testing reagents | 64 | 1,020 | £1.5K | -5.4% ▼ |
| 64 | 141 | £826 | +79.0% ▲ | |
| Peppermint oil | 63 | 6,714 | £732 | -20.8% ▼ |
| Prednisolone | 63 | 1,656 | £177 | -12.4% ▼ |
| Sodium cromoglicate | 63 | 1,227 | £323 | -32.2% ▼ |
| 63 | 1,642 | £141 | +26.3% ▲ | |
| Leflunomide | 61 | 4,050 | £415 | +61.2% ▲ |
| 61 | 5,020 | £636 | -10.9% ▼ | |
| Ranolazine | 60 | 4,532 | £808 | -64.7% ▼ |
| Phenobarbital | 60 | 3,798 | £522 | +95.1% ▲ |
| Pramipexole | 59 | 6,424 | £816 | -39.9% ▼ |
| Mycophenolate mofetil | 59 | 7,302 | £1.7K | +45.7% ▲ |
| Pizotifen malate | 58 | 3,584 | £154 | -29.6% ▼ |
| Timolol | 58 | 940 | £403 | -34.4% ▼ |
| Biphasic insulin lispro | 57 | 455 | £2.8K | +32.8% ▲ |
| Dorzolamide and timolol | 57 | 2,805 | £1.5K | -60.2% ▼ |
| 57 | 150 | £876 | +221.3% ▲ | |
| Sennosides | 56 | 15.8K | £348 | +81.3% ▲ |
| Ciprofloxacin | 56 | 1,421 | £197 | +40.4% ▲ |
| Combined ethinylestradiol 30mcg | 56 | 4,732 | £203 | -79.8% ▼ |
| Mefenamic acid | 56 | 2,380 | £452 | +24.0% ▲ |
| Latanoprost and timolol | 56 | 1,775 | £1.1K | -26.7% ▼ |
| 56 | 1,032 | £2.6K | +101.3% ▲ | |
| Valsartan | 55 | 1,876 | £442 | -6.6% ▼ |
| Naratriptan hydrochloride | 55 | 714 | £137 | +110.4% ▲ |
| Powder extensively hydrolysed formula (0913101) | 55 | 177.2K | £4.9K | -23.7% ▼ |
| 55 | 613 | £924 | +454.7% ▲ | |
| Primidone | 54 | 4,984 | £6.5K | +51.7% ▲ |
| Bezafibrate | 53 | 3,048 | £723 | -1.6% vs avg |
| Lacosamide | 53 | 5,080 | £1.4K | -1.4% vs avg |
| Ropinirole hydrochloride | 52 | 4,144 | £1.8K | -51.1% ▼ |
| Solifenacin/tamsulosin | 52 | 2,412 | £2.1K | +153.1% ▲ |
| Calcium carbonate | 52 | 4,426 | £385 | -21.0% ▼ |
| Nicotine | 51 | 892 | £1.2K | -9.7% ▼ |
| Olopatadine | 51 | 295 | £291 | +16.3% ▲ |
| 51 | 93 | £13.1K | +42.8% ▲ | |
| 51 | 1,460 | £1.5K | +328.7% ▲ | |
| Powder amino acid formula (0913107) | 50 | 151.2K | £9.6K | +51.4% ▲ |
| 50 | 288 | £255 | +381.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.